Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

What Better Gout Trials Might Look Like

Executive Summary

FDA comments in Ironwood's Zurampic review suggest what the agency would like to see from gout clinical programs.


Related Content

With Zurampic, FDA Again Made Do With Sorry State Of Regulatory Science In Gout


Related Companies